Literature DB >> 16982059

The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: the Multi-Ethnic Study of Atherosclerosis (MESA).

Paul Holvoet1, Nancy S Jenny, Pamela J Schreiner, Russell P Tracy, David R Jacobs.   

Abstract

Several groups have demonstrated an association between established CHD and elevated oxidized LDL (oxLDL). The relation with cardiovascular risk factors and subclinical CVD is less clear. Therefore, we examined this association in the Multi-Ethnic Study of Atherosclerosis cohort: 879 persons without CHD, all non-statin users, examined cross-sectionally. oxLDL was measured with a monoclonal antibody 4E6-based ELISA. The presence of subclinical CVD was defined as plaque occurrence in carotid arteries with > or = 25 stenosis, ankle-brachial blood pressure index (ABI) < 0.9 and coronary calcification based on Agatston calcium score > or = 200. In a multivariate model, dyslipidemia (adverse levels of cholesterol, HDL-cholesterol, triglycerides), inflammation (elevated fibrinogen), gender (male), ethnicity (Black), and current smoking explained the most variation in oxLDL (model R2=0.41). In bivariate analyses, persons with subclinical CVD had higher levels of oxLDL (1.22 mg/dl versus 0.95 mg/dl; P=0.0002). Adjustment for risk factor correlates attenuated associations with subclinical CVD (P=0.026). In conclusion, oxLDL is associated with subclinical CVD by its relationship with many cardiovascular risk factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982059     DOI: 10.1016/j.atherosclerosis.2006.08.002

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  52 in total

1.  Dietary interventions that lower lipoproteins containing apolipoprotein C-III are more effective in whites than in blacks: results of the OmniHeart trial.

Authors:  Jeremy D Furtado; Hannia Campos; Anne E Sumner; Lawrence J Appel; Vincent J Carey; Frank M Sacks
Journal:  Am J Clin Nutr       Date:  2010-09-08       Impact factor: 7.045

Review 2.  Complicated atheromatous plaque as integral atherogenesis.

Authors:  Lawrence M Agius
Journal:  J Clin Pathol       Date:  2006-11-01       Impact factor: 3.411

3.  PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax-caspase9-caspase3 pathway.

Authors:  Chun-Yan Wu; Zhi-Han Tang; Lu Jiang; Xue-Fei Li; Zhi-Sheng Jiang; Lu-Shan Liu
Journal:  Mol Cell Biochem       Date:  2011-08-17       Impact factor: 3.396

4.  Differences in systemic oxidative stress based on race and the metabolic syndrome: the Morehouse and Emory Team up to Eliminate Health Disparities (META-Health) study.

Authors:  Alanna A Morris; Liping Zhao; Riyaz S Patel; Dean P Jones; Yusuf Ahmed; Neli Stoyanova; Gary H Gibbons; Viola Vaccarino; Rebecca Din-Dzietham; Arshed A Quyyumi
Journal:  Metab Syndr Relat Disord       Date:  2012-03-02       Impact factor: 1.894

5.  Low-volume walking program improves cardiovascular-related health in older adults.

Authors:  Jong-Hwan Park; Masashi Miyashita; Masaki Takahashi; Noriaki Kawanishi; Harumi Hayashida; Hyun-Shik Kim; Katsuhiko Suzuki; Yoshio Nakamura
Journal:  J Sports Sci Med       Date:  2014-09-01       Impact factor: 2.988

Review 6.  Biomarkers of Key Biological Pathways in CVD.

Authors:  Nancy Swords Jenny; Nels C Olson; Matthew A Allison; Dena E Rifkin; Lori B Daniels; Ian H de Boer; Christina L Wassel; Russell P Tracy
Journal:  Glob Heart       Date:  2016-09

7.  Relationship of serum cholesterol levels to atopy in the US population.

Authors:  M B Fessler; R Jaramillo; P W Crockett; D C Zeldin
Journal:  Allergy       Date:  2009-12-16       Impact factor: 13.146

8.  Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study.

Authors:  Omer T Njajou; Alka M Kanaya; Paul Holvoet; Stephanie Connelly; Elsa S Strotmeyer; Tamara B Harris; Steve R Cummings; Wen-Chi Hsueh
Journal:  Diabetes Metab Res Rev       Date:  2009-11       Impact factor: 4.876

9.  The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study.

Authors:  Maria F Lopes-Virella; Kelly J Hunt; Nathaniel L Baker; Gabriel Virella; Thomas Moritz
Journal:  Atherosclerosis       Date:  2012-08-21       Impact factor: 5.162

10.  Low-Density Lipoprotein Cholesterol Concentrations and Association of High-Sensitivity C-Reactive Protein Concentrations With Incident Coronary Heart Disease in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Gen-Min Lin; Kiang Liu; Laura A Colangelo; Susan G Lakoski; Russell P Tracy; Philip Greenland
Journal:  Am J Epidemiol       Date:  2015-11-22       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.